franckreporter/iStock via Getty Images
- Celyad Oncology (NASDAQ:CYAD) +31% raises $32.5M in private placement with Fortress Investment Group.
- Longeveron (NASDAQ:LGVN) +26% on FDA orphan designation to Lomecel-B
- Marvell Technology (NASDAQ:MRVL) +22% after third-quarter earnings beat
- Code Chain New Continent (NASDAQ:CCNC) +11%.
- Zillow (NASDAQ:Z) +10% updates progress on Zillow Offers inventory wind-down, authorizes $750M in share repurchase
- Cardiol Therapeutics (NASDAQ:CRDL) +8%.
- Aurora Mobile (NASDAQ:JG) +7%.
- Tivic Health (NASDAQ:TIVC) +7%.
- PetVivo Holdings (NASDAQ:PETV) +6%.
- Huaneng Power International (NYSE:HNP) +6%.
- Marpai (NASDAQ:MRAI) +6%.
- Fastly (NYSE:FSLY) +6%.
- Upstart (NASDAQ:UPST) +6%.
- iSpecimen (NASDAQ:ISPC) +6% expands supplier network of human biospecimens to help advance research in neurological disorders
- Moderna (NASDAQ:MRNA) +6% FDA to speed up review of Omicron-specific vaccines and drugs - WSJ
- XpresSpa Group (NASDAQ:XSPA) +6%.
- Novavax (NASDAQ:NVAX) +6% Prior infection may not protect against Omicron COVID variant: S. Africa microbiologist
- Meta Materials (NASDAQ:MMAT) +5%.
- UiPath (NYSE:PATH) +5% gets upgraded to overweight at Morgan Stanley, $74 PT